Global Health Ltd Approves Q1 Results and Expands Guwahati Hospital Capacity to 650 Beds
Global Health Ltd (GHL) announced several key strategic decisions following its Board of Directors meeting on July 30, 2026. The company approved its unaudited standalone and consolidated financial results for the first quarter ending June 30, 2026. Furthermore, GHL greenlit a revised construction plan for its upcoming hospital in Guwahati, significantly increasing the proposed bed capacity.The Board meeting also saw the appointment of new leadership and set corporate timelines related to shareholder dividends and the forthcoming Annual General Meeting (AGM).
Financial Performance Highlights
Global Health Ltd's standalone and consolidated unaudited financial results for the quarter ended June 30, 2026, reflect operations across its various segments. The results were reviewed by the Audit Committee and the statutory auditors.Key performance metrics for the quarter, compared to prior periods (figures in millions), are detailed below:
Standalone Financial Results (Quarter Ended 30 June 2026)
| Particulars | Qtr Ended 30 June 2026 | Qtr Ended 31 March 2026 | Qtr Ended 30 June 2025 | Year Ended 31 March 2026 |
|---|---|---|---|---|
| Revenue from Operations | 10,787.23 | 9,606.29 | 8,821.56 | 37,093.78 |
| Total Income | 11,027.83 | 9,964.34 | 9,052.95 | 38,157.86 |
| Total Expenses | 9,196.73 | 8,329.59 | 7,266.41 | 31,665.09 |
| Profit Before Tax | 1,831.10 | 1,634.75 | 1,786.54 | 6,492.77 |
| Profit After Tax (Standalone) | 1,373.07 | 1,241.31 | 1,519.64 | 4,962.01 |
Consolidated Financial Results (Quarter Ended 30 June 2026)
| Particulars | Qtr Ended 30 June 2026 | Qtr Ended 31 March 2026 | Qtr Ended 30 June 2025 | Year Ended 31 March 2026 |
|---|---|---|---|---|
| Revenue from Operations | 13,040.51 | 11,590.47 | 10,308.44 | 44,102.66 |
| Total Income | 13,262.15 | 11,957.89 | 10,512.94 | 45,088.60 |
| Total Expenses | 11,129.52 | 10,085.10 | 8,627.45 | 37,928.22 |
| Profit Before Tax | 2,132.63 | 1,872.79 | 1,885.49 | 7,160.38 |
| Profit After Tax (Consolidated) | 1,572.52 | 1,416.53 | 1,589.82 | 5,540.68 |
Strategic Expansion and Operational Updates
The Board approved a major expansion plan for the company's hospital in Guwahati. The revised construction plan will increase the proposed bed capacity from 400 beds to 650 beds.The estimated project cost for the facility is Rs. 970 crores, with the project planned to be financed through internal accruals and debt. The rationale provided states that the strategically located site offers seamless connectivity across the North East region, aiming to serve over 50 million people in Assam and neighbouring states.
Corporate Appointments and Shareholder Matters
The Board also announced the appointment of Mr. Pradeep Kumar Singh as Chief Digital Officer (CDO) and a Senior Management Personnel (SMP), effective July 30, 2026. Mr. Singh possesses over 25 years of experience in technology leadership and digital transformation.In matters related to corporate governance, the Board set the record date for dividend entitlement at Friday, August 14, 2026. This record date relates to the payment of a final dividend of Rs. 0.50/- per equity share for the financial year 2025-26, which is subject to approval by shareholders at the upcoming 22nd Annual General Meeting (AGM).
The AGM is scheduled to be held on Wednesday, September 16, 2026, through Video Conferencing or other Audio Visual Means.
MEDANTA Stock Price Movement
Today, Global Health Limited stock slipped by 0.69% to close at ₹1416.4 after the market session. Trading activity saw the equity transact 234,633 shares during the day.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.